Zhejiang Sunflower Great Health Co., Ltd Class A

Zhejiang Sunflower Great Health Co., Ltd Class A

SSZSE:300111
2.90
CNY
-0.20
(-6.45%)
-0.02EPS
3.84BMarket Cap

Total Valuation

CNY

As of September 30, 2026, Zhejiang Sunflower Great Health Co., Ltd Class A carries a market capitalization of 3.84B, placing it among publicly traded companies globally. Its enterprise value stands at 3.49B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap3.84B
Enterprise Value3.49B

Share Statistics

As of September 30, 2026, Zhejiang Sunflower Great Health Co., Ltd Class A has 1.29B shares outstanding.

Shares Outstanding1.29B

Valuation Ratios

These figures are as of September 30, 2026. The price-to-sales ratio is 15.71, and the price-to-book ratio stands at 5.76.

PS Ratio15.71
PB Ratio5.76
P/TBV Ratio6.30

Enterprise Valuation

These figures are as of September 30, 2026. The EV/Sales ratio of 14.34 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 3.49B versus a market cap of 3.84B, with the gap driven by net debt and cash on the balance sheet.

EV / Sales14.34

Financial Position

As of September 30, 2026, Zhejiang Sunflower Great Health Co., Ltd Class A maintains a current ratio of 6.74, meaning it holds 6.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 0.15, indicating conservative leverage, while an interest coverage ratio of -550,097.39 demonstrates limited ability to service its debt obligations.

Current Ratio6.74
Quick Ratio4.38
Debt / Equity0.15
Debt / EBITDA-0.08
Interest Coverage-550,097.39

Financial Efficiency

CNY

Over the twelve months ended September 30, 2026, Zhejiang Sunflower Great Health Co., Ltd Class A posted a negative return on equity (ROE) of -3.15, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -2.22, reflecting losses generated across the asset base. The company generates approximately 803,699.93 in revenue per employee across its workforce of 303.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 1.22 indicates how many times Zhejiang Sunflower Great Health Co., Ltd Class A sells and replaces its inventory over a year, a key working capital efficiency ratio.

Return on Equity (ROE)-3.15
Return on Assets (ROA)-2.22
Revenue Per Employee803,699.93
Employee Count303.00
Inventory Turnover1.22

Taxes

CNY

Over the twelve months ended September 30, 2026, Zhejiang Sunflower Great Health Co., Ltd Class A recorded an income tax benefit of -958,442.83 rather than an expense, typically from losses, carryforwards, or the release of a tax provision. The company reported a pretax loss of -20.99M and -21.32M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

Income Tax-958,442.83

Stock Price Statistics

CNY

As of the close on November 17, 2026, Zhejiang Sunflower Great Health Co., Ltd Class A's stock has declined approximately 62.29% over the past 52 weeks. The 50-day moving average sits at 3.22, while the 200-day moving average is 3.56.

52-Week Price Change-62.29%
50-Day Moving Average3.22
200-Day Moving Average3.56

Income Statement

CNY

Over the twelve months ended September 30, 2026, Zhejiang Sunflower Great Health Co., Ltd Class A generated 243.52M in revenue and converted that into -21.32M in net income, yielding earnings per share of -0.02. EBITDA reached -14.98M, while operating income came in at -5.25M.

Revenue243.52M
Gross Profit51.42M
Operating Income-5.25M
Pretax Income-20.99M
Net Income-21.32M
EBITDA-14.98M
EBIT-14.98M
Earnings Per Share (EPS)-0.02

Balance Sheet

CNY

As of September 30, 2026, Zhejiang Sunflower Great Health Co., Ltd Class A holds 484.26M in cash and equivalents against 1.18M in total debt, resulting in a net debt position of -372.96M. Total book value stands at 666.47M, with working capital of 635.53M providing operational flexibility.

Cash & Cash Equivalents484.26M
Total Debt1.18M
Net Debt-372.96M
Equity (Book Value)666.47M
Book Value Per Share0.52
Working Capital635.53M

Cash Flow

CNY

These figures cover the twelve months ended September 30, 2026.

Capital Expenditures-5.71M

Margins

Over the twelve months ended September 30, 2026, Zhejiang Sunflower Great Health Co., Ltd Class A posted a gross margin of 21.11, reflecting its pricing power and cost economics. The operating margin of -2.16 and net profit margin of -8.75 provide insight into operational efficiency.

Gross Margin21.11
Operating Margin-2.16
Pretax Margin-8.62
Profit Margin-8.75
EBITDA Margin-6.15

Dividends & Yields

CNY

Over the twelve months ended September 30, 2026, Zhejiang Sunflower Great Health Co., Ltd Class A paid dividends of -NaN per share. The dividend payout ratio of 0.00 is negative because earnings are negative, so the dividend is being paid out of something other than profits, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth.

Dividend Per Share-NaN

Stock Splits

Zhejiang Sunflower Great Health Co., Ltd Class A's most recent stock split took place on September 4, 2013 with a 5:11 split ratio.

Last Split Date9/4/2013
Split Ratio5:11

Scores

As of September 30, 2026, Zhejiang Sunflower Great Health Co., Ltd Class A has an Altman Z-Score of 16.49, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score16.49